Published in Ann Intern Med on April 01, 1987
Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ (1996) 6.25
Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med (2008) 3.94
What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study. Thorax (2005) 3.66
Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation. Cancer Cell (2010) 2.89
Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med (2011) 2.77
Mechanistic links between COPD and lung cancer. Nat Rev Cancer (2013) 2.28
Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway. Cancer Prev Res (Phila) (2009) 2.06
Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax (2007) 2.05
Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax (2005) 1.92
Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis. Proc Natl Acad Sci U S A (2007) 1.89
Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research. J Natl Cancer Inst (2009) 1.75
Previous lung diseases and lung cancer risk: a systematic review and meta-analysis. PLoS One (2011) 1.62
Quantitative computed tomography analysis, airflow obstruction, and lung cancer in the pittsburgh lung screening study. J Thorac Oncol (2011) 1.57
Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients. Int J Chron Obstruct Pulmon Dis (2012) 1.45
Pathogenesis of lung cancer: 100 year report. Am J Respir Cell Mol Biol (2005) 1.44
Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model. Am J Respir Cell Mol Biol (2008) 1.44
Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers. Thorax (2006) 1.36
The genetics of chronic obstructive pulmonary disease. Respir Res (2001) 1.33
Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function. Am J Respir Crit Care Med (2011) 1.26
Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 1.26
Predictors of mortality in alpha1-antitrypsin deficiency. Thorax (2003) 1.24
Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPD. PLoS One (2011) 1.20
Oral iloprost improves endobronchial dysplasia in former smokers. Cancer Prev Res (Phila) (2011) 1.14
Nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease and lung cancer. Int J Chron Obstruct Pulmon Dis (2011) 1.11
Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease. Thorax (1999) 1.10
Gene by Environment Interaction Linking the Chromosome 15q25 Locus With Cigarette Consumption and Lung Cancer Susceptibility - Are African American Affected Differently? EBioMedicine (2016) 1.06
Decline of lung function and development of chronic airflow limitation: a longitudinal study of non-smokers and smokers in Busselton, Western Australia. Thorax (1990) 1.04
Lung injury and cancer: Mechanistic insights into ceramide and EGFR signaling under cigarette smoke. Am J Respir Cell Mol Biol (2010) 1.03
Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment. Thorax (2006) 1.02
Mortality from lung cancer among Sardinian patients with silicosis. Br J Ind Med (1991) 1.00
Update in lung cancer 2007. Am J Respir Crit Care Med (2008) 1.00
Detection of early lung cancer. Thorax (2000) 0.97
FAM13A locus in COPD is independently associated with lung cancer - evidence of a molecular genetic link between COPD and lung cancer. Appl Clin Genet (2010) 0.97
Epithelial nuclear factor-κB signaling promotes lung carcinogenesis via recruitment of regulatory T lymphocytes. Oncogene (2011) 0.96
Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis. Cancer Prev Res (Phila) (2010) 0.95
Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score. Am J Respir Crit Care Med (2015) 0.94
Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice. Carcinogenesis (2009) 0.94
Influence of cardiorespiratory fitness on lung cancer mortality. Med Sci Sports Exerc (2010) 0.94
Genetic evidence linking lung cancer and COPD: a new perspective. Appl Clin Genet (2011) 0.93
Transcriptional profiling of the acute pulmonary inflammatory response induced by LPS: role of neutrophils. Respir Res (2010) 0.92
Polymorphisms in the promoter region of neutrophil elastase gene and lung cancer risk. Lung Cancer (2005) 0.88
Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 0.88
Prospective study of physical activity and lung cancer by histologic type in current, former, and never smokers. Am J Epidemiol (2009) 0.87
Does smoking influence the physical activity and lung cancer relation? A systematic review and meta-analysis. Eur J Epidemiol (2016) 0.87
Socio-economic status and overall and cause-specific mortality in Sweden. BMC Public Health (2008) 0.87
Polymorphisms for microsomal epoxide hydrolase and genetic susceptibility to COPD. Int J Mol Med (2005) 0.87
Correlation of regional emphysema and lung cancer: a lung tissue research consortium-based study. J Thorac Oncol (2014) 0.86
Cancer-prone mice expressing the Ki-rasG12C gene show increased lung carcinogenesis after CT screening exposures. Radiat Res (2011) 0.86
G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer. J Thorac Oncol (2012) 0.86
Mortality from lung cancer among silicotic patients in Sardinia: an update study with 10 more years of follow up. Occup Environ Med (2001) 0.85
Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN)-γ by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells. Clin Exp Immunol (2014) 0.85
Allergic inflammation does not impact chemical-induced carcinogenesis in the lungs of mice. Respir Res (2010) 0.85
Genetic analysis of microsomal epoxide hydrolase gene and its association with lung cancer risk. Eur J Cancer Prev (2005) 0.83
Chronic rhinosinusitis and risk of lung cancer in the Singapore Chinese Health Study. Int J Cancer (2008) 0.83
Association of interleukin 1 beta (IL-1β) polymorphism with mRNA expression and risk of non small cell lung cancer. Meta Gene (2014) 0.81
Chemoprevention of lung cancer. Proc Am Thorac Soc (2009) 0.81
Polymorphisms of NRF2 gene correlated with decreased FEV1 in lung cancers of smokers. Biomed Rep (2013) 0.79
GSTM1 null genotype in COPD and lung cancer: evidence of a modifier or confounding effect? Appl Clin Genet (2011) 0.78
Lung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repository. BMC Pulm Med (2016) 0.77
The relationship between stage 1 and 2 non-small cell lung cancer and lung function in men and women. BMC Pulm Med (2006) 0.77
Spectrum of cancer risk among Taiwanese with chronic obstructive pulmonary disease. Int J Clin Oncol (2016) 0.77
Systematic review with meta-analysis of the epidemiological evidence relating FEV1 decline to lung cancer risk. BMC Cancer (2012) 0.77
Biomarkers of carcinogen exposure and cancer risk in a coke plant. Environ Health Perspect (1993) 0.77
Overwhelming support among urban Irish COPD patients for lung cancer screening by low-dose CT scan. Lung (2012) 0.76
Collagenolytic matrix metalloproteinases in chronic obstructive lung disease and cancer. Cancers (Basel) (2015) 0.76
Incidence and relative risk for developing cancer among patients with COPD: a nationwide cohort study in Taiwan. BMJ Open (2017) 0.75
Squamous Metaplasia Is Increased in the Bronchial Epithelium of Smokers with Chronic Obstructive Pulmonary Disease. PLoS One (2016) 0.75
Lung cancer screening in patients with chronic obstructive pulmonary disease. Ann Transl Med (2016) 0.75
Lung cancer chemoprevention. Proc Am Thorac Soc (2012) 0.75
Endogenous modifiers of cigarette smoke exposure within the lung. Proc Am Thorac Soc (2012) 0.75
Self-reported prior lung diseases as risk factors for non-small cell lung cancer in Mexican Americans. J Immigr Minor Health (2013) 0.75
Biomarkers in Exhaled Breath Condensate and Serum of Chronic Obstructive Pulmonary Disease and Non-Small-Cell Lung Cancer. Int J Chronic Dis (2013) 0.75
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med (1987) 8.41
Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med (2001) 4.48
Mortality in COPD: Role of comorbidities. Eur Respir J (2006) 4.14
Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis (1986) 3.03
Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med (1992) 3.01
Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers. Eur Respir J (2006) 2.85
Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood (1997) 2.74
Measurement of anticonvulsant adherence behaviour in the community using a Medication Events Monitoring System (MEMS) Health Care Anal (1998) 2.70
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69
Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N Engl J Med (1976) 2.67
Utility of adiponectin as a biomarker predictive of glycemic efficacy is demonstrated by collaborative pooling of data from clinical trials conducted by multiple sponsors. Clin Pharmacol Ther (2009) 2.60
Airway closure as a function of age. Respir Physiol (1969) 2.53
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax (2006) 2.38
Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study. Ann Intern Med (1978) 2.29
Mouse allergen. II. The relationship of mouse allergen exposure to mouse sensitization and asthma morbidity in inner-city children with asthma. J Allergy Clin Immunol (2000) 2.20
Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study. Hepatology (2001) 2.13
Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis (1984) 2.11
Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease. Arch Intern Med (1984) 2.07
Mouse allergen. I. The prevalence of mouse allergen in inner-city homes. The National Cooperative Inner-City Asthma Study. J Allergy Clin Immunol (2000) 2.05
Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med (2001) 2.03
Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis (1989) 2.03
Associations of IL6 polymorphisms with lung function decline and COPD. Thorax (2009) 2.00
A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med (1994) 1.99
Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis (1986) 1.87
Sex and race differences in the development of lung function. Am Rev Respir Dis (1988) 1.83
Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci U S A (1994) 1.81
Steroid response in stable chronic obstructive pulmonary disease. Ann Intern Med (1982) 1.80
Thrombosis with low-estrogen oral contraceptives. Am J Epidemiol (1975) 1.78
Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J (2008) 1.76
Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers. Thorax (2001) 1.72
Regional lung function in patients with chronic bronchitis. Clin Sci (1968) 1.69
Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med (1997) 1.65
Microsatellite instability at AAAG repeat sequences in respiratory tract cancers. Int J Cancer (2001) 1.62
Efficacy of hepatitis B immune serum globulin after accidental exposure. Preliminary report of the Veterans Administration Cooperative Study. Lancet (1975) 1.59
Respiratory effects on household exposures to tobacco smoke and gas cooking. Am Rev Respir Dis (1981) 1.58
Results of the National Cooperative Inner-City Asthma Study (NCICAS) environmental intervention to reduce cockroach allergen exposure in inner-city homes. J Allergy Clin Immunol (1999) 1.57
Distribution of pulmonary perfusion in erect man. J Appl Physiol (1966) 1.57
A common familial component in lung cancer and chronic obstructive pulmonary disease. Lancet (1977) 1.55
Risk factors in chronic obstructive pulmonary disease (COPD). Am J Epidemiol (1977) 1.50
Short-term compliance with peak flow monitoring: results from a study of inner city children with asthma. Pediatr Pulmonol (1996) 1.48
Anxiety disorders in major depression. Compr Psychiatry (2000) 1.46
Income level and asthma prevalence and care patterns. Am J Respir Crit Care Med (1997) 1.44
A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group. N Engl J Med (1992) 1.42
Risk factors and early detection of lung cancer in a cohort of Chinese tin miners. Ann Epidemiol (1997) 1.42
Comparison of responses to methacholine and cold air in patients suspected of having asthma. Chest (1989) 1.40
Loss of heterogeneous ribonucleoprotein A(2)/B(1) expression in thyroid neoplasms. Endocr Pract (2001) 1.39
Natural history and course of acquired lactic acidosis in adults. DCA-Lactic Acidosis Study Group. Am J Med (1994) 1.38
Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. Atherosclerosis Risk in Communities Study Investigators. N Engl J Med (1994) 1.36
Prevalence of asthma symptoms among adults aged 20-44 years in Canada. CMAJ (2001) 1.33
The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse. Ann Intern Med (2001) 1.30
Trends in physician-diagnosed asthma prevalence in Manitoba between 1980 and 1990. Chest (1993) 1.27
Effect of inspiratory flow rate on regional distribution of inspired gas. J Appl Physiol (1969) 1.27
Serum retinol and airway obstruction. Am J Epidemiol (1990) 1.26
Regional structure and function in bronchiectasis. A correlative study using bronchography and 133Xe. Am Rev Respir Dis (1968) 1.26
Comparison of three standardized questionnaires on respiratory symptoms. Am Rev Respir Dis (1979) 1.24
Inheritance of proliferative breast disease in breast cancer kindreds. Science (1990) 1.24
Effects of pulmonary function on mortality. J Chronic Dis (1985) 1.24
Standardized respiratory questionnaires: comparison of the old with the new. Am Rev Respir Dis (1979) 1.24
Evolution of remission as the new standard in the treatment of depression. J Clin Psychiatry (1999) 1.23
New Haven survey of joint diseases. XI. Observer variability in the assessment of x-rays for osteoarthrosis of the hands. Am J Epidemiol (1970) 1.22
Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol Biomarkers Prev (2001) 1.18
The effect of self-care interventions on the use of medical service within a Medicare population. Med Care (1988) 1.18
Human lung homotransplantation. Can Med Assoc J (1966) 1.16
Predicting episodes of poor asthma control in treated patients with asthma. J Allergy Clin Immunol (2006) 1.16
Analysis of spirometric data from a national sample of healthy 6- to 24-year-olds (NHANES II). Am Rev Respir Dis (1988) 1.16
Monocyte infiltration and kidney allograft dysfunction during acute rejection. Am J Transplant (2008) 1.15
Progressive neuropsychologic impairment and hypoxemia. Relationship in chronic obstructive pulmonary disease. Arch Gen Psychiatry (1987) 1.15
Ventilatory response to sustained hypoxia in normal adults. J Appl Physiol (1985) (1986) 1.14
Effects of multiple attempts to quit smoking and relapses to smoking on pulmonary function. Lung Health Study Research Group. J Clin Epidemiol (1998) 1.13
Endogenous opiates and chemical control of breathing in humans. Am Rev Respir Dis (1980) 1.12
A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence. N Engl J Med (1986) 1.12
Long-term oxygen therapy. Ann Intern Med (1983) 1.11
Geographical variations in the prevalence of atopic sensitization in six study sites across Canada. Allergy (2010) 1.11
Ventilatory response to moderate hypoxia in awake chemodenervated cats. J Appl Physiol (1985) (1993) 1.11
Glutathionuria: gamma-glutamyl transpeptidase deficiency. J Inherit Metab Dis (1980) 1.10
Enzymatic control of phenylalanine intake in phenylketonuria. Lancet (1980) 1.09
Radiographic screening in the early detection of lung cancer. Radiol Clin North Am (1978) 1.09
Collaborative study to assess risk of lung disease in Pi MZ phenotype subjects. Am Rev Respir Dis (1984) 1.08
Agreement rates between oral contraceptive users and prescribers in relation to drug use histories. Am J Epidemiol (1978) 1.06
Biological monitoring of fire fighters: sister chromatid exchange and polycyclic aromatic hydrocarbon-DNA adducts in peripheral blood cells. Cancer Res (1989) 1.05
Pulmonary function and respiratory symptoms in wildland firefighters. J Occup Med (1991) 1.05
Randomised clinical trial: the benefit of combination therapy with adefovir and lamivudine for chronic hepatitis B. Aliment Pharmacol Ther (2012) 1.04
A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. A Veterans Administration cooperative study. Gastroenterology (1977) 1.04
Self-reported adherence, management behavior, and barriers to care after an emergency department visit by inner city children with asthma. Pediatrics (1998) 1.04
Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial. Aliment Pharmacol Ther (2010) 1.04
Demographic and anthropometric correlates of maximum inspiratory pressure: The Atherosclerosis Risk in Communities Study. Am J Respir Crit Care Med (1999) 1.02
Respiratory symptoms in a susceptible population due to burning of agricultural residue. Chest (1998) 1.02
Smoking, lung function, and mortality. Thorax (2000) 1.00
Sputum cytopathology: use and potential in monitoring the workplace environment by screening for biological effects of exposure. J Occup Med (1986) 1.00
Evidence against the reported linkage of the cutaneous melanoma-dysplastic nevus syndrome locus to chromosome Ip36. Am J Hum Genet (1990) 1.00
Polymorphisms in the beta2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers. Thorax (2003) 0.99
Characteristics of participants who stop smoking and sustain abstinence for 1 and 5 years in the Lung Health Study. Prev Med (2000) 0.99
Hepatic disease in asymptomatic parenteral narcotic drug abusers: a Veterans Administration collaborative study. Am J Med Sci (1976) 0.99
Lung Health Study. Am Rev Respir Dis (1989) 0.99
Ventilatory control in patients with hypoxemia due to obstructive lung disease. Am Rev Respir Dis (1979) 0.99